{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:41:02Z","timestamp":1772833262819,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","award":["IG 2018\u2014ID. 21846"],"award-info":[{"award-number":["IG 2018\u2014ID. 21846"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"P.I. Michele Ceccarelli and from Italian Ministry of Research","award":["PRIN 2017XJ38A4_004"],"award-info":[{"award-number":["PRIN 2017XJ38A4_004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>The cost of drug development has dramatically increased in the last decades, with the number new drugs approved per billion US dollars spent on R&amp;D halving every year or less. The selection and prioritization of targets is one the most influential decisions in drug discovery. Here we present a Gaussian Process model for the prioritization of drug targets cast as a problem of learning with only positive and unlabeled examples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Since the absence of negative samples does not allow standard methods for automatic selection of hyperparameters, we propose a novel approach for hyperparameter selection of the kernel in One Class Gaussian Processes. We compare our methods with state-of-the-art approaches on benchmark datasets and then show its application to druggability prediction of oncology drugs. Our score reaches an AUC 0.90 on a set of clinical trial targets starting from a small training set of 102 validated oncology targets. Our score recovers the majority of known drug targets and can be used to identify novel set of proteins as drug target candidates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>The matrix of features for each protein is available at: https:\/\/bit.ly\/3iLgZTa. Source code implemented in Python is freely available for download at https:\/\/github.com\/AntonioDeFalco\/Adaptive-OCGP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Supplementary information<\/jats:title>\n                  <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btaa968","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T20:18:18Z","timestamp":1604434698000},"page":"1420-1427","source":"Crossref","is-referenced-by-count":6,"title":["Adaptive one-class Gaussian processes allow accurate prioritization of oncology drug targets"],"prefix":"10.1093","volume":"37","author":[{"given":"Antonio","family":"de Falco","sequence":"first","affiliation":[{"name":"BIOGEM Istituto di Ricerche Genetiche \u201cG. Salvatore \u201d, 83031 Ariano Irpino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Dezso","sequence":"additional","affiliation":[{"name":"ABBVIE Biotherapeutics , Redwood City, CA 94063, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ceccarelli","sequence":"additional","affiliation":[{"name":"Donald Bren School of Information and Computer Sciences (ICS) , Irvine, CA 92697, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-3487","authenticated-orcid":false,"given":"Luigi","family":"Cerulo","sequence":"additional","affiliation":[{"name":"BIOGEM Istituto di Ricerche Genetiche \u201cG. Salvatore \u201d, 83031 Ariano Irpino, Italy"},{"name":"Department of Science and Technologies, University of Sannio , 82100 Benevento, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Ciaramella","sequence":"additional","affiliation":[{"name":"Department Science and Technology, University of Naples Parthenope , 80133 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Ceccarelli","sequence":"additional","affiliation":[{"name":"BIOGEM Istituto di Ricerche Genetiche \u201cG. Salvatore \u201d, 83031 Ariano Irpino, Italy"},{"name":"Department of Electrical Engineering and Information Technology (DIETI), University of Naples\u201d Federico II\u201d , 80128 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,17]]},"reference":[{"key":"2023051709342087300_btaa968-B1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/nar\/27.1.49","article-title":"The SWISS-PROT protein sequence data bank","volume":"27","author":"Bairoch","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"2023051709342087300_btaa968-B2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/bioinformatics\/btp002","article-title":"Properties and identification of human protein drug targets","volume":"25","author":"Bakheet","year":"2009","journal-title":"Bioinformatics"},{"key":"2023051709342087300_btaa968-B3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mc.22475","article-title":"Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model","volume":"56","author":"Bauer","year":"2017","journal-title":"Mol. Carcinog"},{"key":"2023051709342087300_btaa968-B4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"2023051709342087300_btaa968-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-11-228","article-title":"Learning gene regulatory networks from only positive and unlabeled data","volume":"11","author":"Cerulo","year":"2010","journal-title":"BMC Bioinf"},{"key":"2023051709342087300_btaa968-B6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fgene.2018.00499","article-title":"Emerging roles of fibroblast growth factor 10 in cancer","volume":"9","author":"Clayton","year":"2018","journal-title":"Front. Genet"},{"key":"2023051709342087300_btaa968-B7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2016-03-679209","article-title":"Therapeutic targeting of IL-7R signaling pathways in all treatment","volume":"128","author":"Cramer","year":"2016","journal-title":"Blood"},{"key":"2023051709342087300_btaa968-B8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12859-020-3442-9","article-title":"Machine learning prediction of oncology drug targets based on protein and network properties","volume":"21","author":"Dezs\u00f6","year":"2020","journal-title":"BMC Bioinformatics"},{"key":"2023051709342087300_btaa968-B9","first-page":"213","article-title":"Learning classifiers from only positive and unlabeled data","author":"Elkan","year":"2008"},{"key":"2023051709342087300_btaa968-B10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1109\/TKDE.2008.239","article-title":"Learning from imbalanced data","volume":"21","author":"He","year":"2009","journal-title":"IEEE Trans. Knowl. Data Eng"},{"key":"2023051709342087300_btaa968-B11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1478-811X-11-97","article-title":"Targeting the pdgf signaling pathway in tumor treatment","volume":"11","author":"Heldin","year":"2013","journal-title":"Cell Commun. Signal. CCS"},{"key":"2023051709342087300_btaa968-B12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/s1677-5538.ibju.2018.0261","article-title":"Role of adiponectin in prostate cancer","volume":"45","author":"Hu","year":"2019","journal-title":"Int. Braz. J. Urol"},{"key":"2023051709342087300_btaa968-B13","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.7150\/ijbs.33881","article-title":"FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma","volume":"15","author":"Huang","year":"2019","journal-title":"Int. J. Biol. Sci"},{"key":"2023051709342087300_btaa968-B14","doi-asserted-by":"crossref","first-page":"17417","DOI":"10.1038\/srep17417","article-title":"Drug target prioritization by perturbed gene expression and network information","volume":"5","author":"Isik","year":"2015","journal-title":"Sci. Rep"},{"key":"2023051709342087300_btaa968-B15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neo.2017.03.002","article-title":"Characterization and targeting of platelet-derived growth factor receptor alpha (PDGFRA) in inflammatory breast cancer (IBC)","volume":"19","author":"Joglekar-Javadekar","year":"2017","journal-title":"Neoplasia"},{"key":"2023051709342087300_btaa968-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/LGRS.2016.2557315","article-title":"One-class Gaussian process for possibilistic classification using imaging spectroscopy","volume":"13","author":"Kalantari","year":"2016","journal-title":"IEEE Geosci. Remote Sens. Lett"},{"key":"2023051709342087300_btaa968-B17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2159-8290.CD-14-0650","article-title":"Notch decoys that selectively block dll\/notch or jag\/notch disrupt angiogenesis by unique mechanisms to inhibit tumor growth","volume":"5","author":"Kangsamaksin","year":"2015","journal-title":"Cancer Discov"},{"key":"2023051709342087300_btaa968-B18","first-page":"1","author":"Kapoor","year":"2007"},{"key":"2023051709342087300_btaa968-B19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11263-009-0268-3","article-title":"Gaussian processes for object categorization","volume":"88","author":"Kapoor","year":"2010","journal-title":"Int. J. Comput. Vis"},{"key":"2023051709342087300_btaa968-B20","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.2174\/1381612823666170208123553","article-title":"Adiponectin as a potential therapeutic target for prostate cancer","volume":"23","author":"Karnati","year":"2017","journal-title":"Curr. Pharm. Des"},{"key":"2023051709342087300_btaa968-B21","article-title":"One-class classification with Gaussian processes","volume":"46","author":"et","year":"2010","journal-title":"Pattern\u00a0Recognit."},{"key":"2023051709342087300_btaa968-B22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12859-017-1639-3","article-title":"In silico re-identification of properties of drug target proteins","volume":"18","author":"Kim","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"2023051709342087300_btaa968-B23","doi-asserted-by":"crossref","first-page":"1555011","DOI":"10.1142\/S0218001415550113","article-title":"Anomaly detection in video surveillance via Gaussian process","volume":"29","author":"Li","year":"2015","journal-title":"Int. J. Pattern Recogn. Artif. Intell"},{"key":"2023051709342087300_btaa968-B24","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Li","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2023051709342087300_btaa968-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12928-6","article-title":"A Bayesian machine learning approach for drug target identification using diverse data types","volume":"10","author":"Madhukar","year":"2019","journal-title":"Nat. Commun"},{"key":"2023051709342087300_btaa968-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06916-5","article-title":"Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration","volume":"9","author":"McFarland","year":"2018","journal-title":"Nat. Commun"},{"key":"2023051709342087300_btaa968-B27","author":"Minka","year":"2001"},{"key":"2023051709342087300_btaa968-B28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fgene.2018.00482","article-title":"Fibroblast growth factor 10 in pancreas development and pancreatic cancer","volume":"9","author":"Ndlovu","year":"2018","journal-title":"Front. Genet"},{"key":"2023051709342087300_btaa968-B29","doi-asserted-by":"crossref","first-page":"40115","DOI":"10.18632\/oncotarget.16969","article-title":"Role of delta-like 4 in jagged1-induced tumour angiogenesis and tumour growth","volume":"8","author":"Oon","year":"2017","journal-title":"Oncotarget"},{"key":"2023051709342087300_btaa968-B30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mam.2017.11.007","article-title":"The PDGF\/PDGFR pathway as a drug target","volume":"62","author":"Papadopoulos","year":"2017","journal-title":"Mol. Aspects Med"},{"key":"2023051709342087300_btaa968-B31","volume-title":"Gaussian Processes for Machine Learning","author":"Rasmussen","year":"2006"},{"key":"2023051709342087300_btaa968-B32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat. Rev. Drug Disc"},{"key":"2023051709342087300_btaa968-B34","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1162\/089976601750264965","article-title":"Estimating the support of a high-dimensional distribution","volume":"13","author":"Sch\u00f6lkopf","year":"2001","journal-title":"Neural Comput"},{"key":"2023051709342087300_btaa968-B35","first-page":"405","article-title":"One-class detection of cell states in tumor subtypes","volume":"21","author":"Sokolov","year":"2016","journal-title":"Pac. Sympos. Biocomput"},{"key":"2023051709342087300_btaa968-B36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/LCTT.S60427","article-title":"Epiregulin as a therapeutic target in non-small- cell lung cancer","volume":"6","author":"Sunaga","year":"2015","journal-title":"Lung Cancer Targets Therapy"},{"key":"2023051709342087300_btaa968-B37","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"String v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023051709342087300_btaa968-B38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/B:MACH.0000008084.60811.49","article-title":"Support vector data description","volume":"54","author":"Tax","year":"2004","journal-title":"Mach. Learn"},{"key":"2023051709342087300_btaa968-B39","volume-title":"Comprehensive Medicinal Chemistry II","author":"Triggle","year":"2006"},{"key":"2023051709342087300_btaa968-B40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023051709342087300_btaa968-B41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nmeth.2810","article-title":"Similarity network fusion for aggregating data types on a genomic scale","volume":"11","author":"Wang","year":"2014","journal-title":"Nat. Methods"},{"key":"2023051709342087300_btaa968-B42","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1109\/T-C.1971.223410","article-title":"A direct method of nonparametric measurement selection","volume":"C-20","author":"Whitney","year":"1971","journal-title":"IEEE Trans. Comput"},{"key":"2023051709342087300_btaa968-B43","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1109\/TNNLS.2014.2363457","article-title":"Hyperparameter selection for Gaussian process one-class classification","volume":"26","author":"Xiao","year":"2015","journal-title":"IEEE Trans. Neural Netw. Learn. Syst"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btaa968\/35906161\/btaa968.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/10\/1420\/50360848\/btaa968.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/10\/1420\/50360848\/btaa968.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T09:48:59Z","timestamp":1684316939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/37\/10\/1420\/5962083"}},"subtitle":[],"editor":[{"given":"Martelli","family":"Pier Luigi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,17]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btaa968","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,15]]},"published":{"date-parts":[[2021,1,17]]}}}